MAP1LC3B and Duchenne muscular dystrophy: Expression levels of SQSTM1 (GSE1004_GPL8300_40898_at), MAP1LC3B (GSE1004_GPL8300_39370_at) and BECN1 (GSE1004_GPL8300_39378_at) were decreased in DMD patients (Fig. 2a).